These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9316524

  • 1. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ, Lopez LM, Bell DM, Handberg-Thurmond EM, Marks RG, McGorray S.
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [Abstract] [Full Text] [Related]

  • 2. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB, Daxini BV, Noyce D, Kelly DT.
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [Abstract] [Full Text] [Related]

  • 3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD, Parker AB, Farrell B, Parker JO.
    Circulation; 1995 Feb 15; 91(4):973-8. PubMed ID: 7850984
    [Abstract] [Full Text] [Related]

  • 4. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO, Amies MH, Hawkinson RW, Heilman JM, Hougham AJ, Vollmer MC, Wilson RR.
    Circulation; 1995 Mar 01; 91(5):1368-74. PubMed ID: 7867175
    [Abstract] [Full Text] [Related]

  • 5. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H, Glasser SP.
    J Am Coll Cardiol; 1989 Mar 15; 13(4):786-95. PubMed ID: 2494240
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R, D'Alterio D, Schiattarella M, Boccia A, Greco L, Marsico F.
    Am J Cardiol; 1988 Mar 25; 61(9):44E-51E. PubMed ID: 3126635
    [Abstract] [Full Text] [Related]

  • 7. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
    Rezaković DE, Pavicić L, Majacić M.
    Eur Heart J; 1988 Jan 25; 9 Suppl A():73-81. PubMed ID: 3137073
    [Abstract] [Full Text] [Related]

  • 8. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.
    Mahmarian JJ, Fenimore NL, Marks GF, Francis MJ, Morales-Ballejo H, Verani MS, Pratt CM.
    J Am Coll Cardiol; 1994 Jul 25; 24(1):25-32. PubMed ID: 8006274
    [Abstract] [Full Text] [Related]

  • 9. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.
    Rossetti E, Luca C, Bonetti F, Chierchia SL.
    J Am Coll Cardiol; 1993 Feb 25; 21(2):337-42. PubMed ID: 8425995
    [Abstract] [Full Text] [Related]

  • 10. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA, Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators.
    JAMA; 2004 Jan 21; 291(3):309-16. PubMed ID: 14734593
    [Abstract] [Full Text] [Related]

  • 11. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
    Crean PA, Ribeiro P, Crea F, Davies GJ, Ratcliffe D, Maseri A.
    Am Heart J; 1984 Dec 21; 108(6):1494-500. PubMed ID: 6439019
    [Abstract] [Full Text] [Related]

  • 12. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
    Holdright DR, Katz RJ, Wright CA, Sparrow JL, Sullivan AK, Cunningham AD, Fox KM.
    Br Heart J; 1993 Mar 21; 69(3):223-7. PubMed ID: 8096389
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of long-term administration of transdermal nitroglycerin in asymptomatic patients with effort-induced silent myocardial ischemia.
    Rubboli A, Sangiorgio P, Pavesi PC, Casella G, Mezzetti M, Bracchetti D.
    Cardiology; 1994 Mar 21; 84(4-5):247-54. PubMed ID: 8187108
    [Abstract] [Full Text] [Related]

  • 14. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
    Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH.
    J Am Coll Cardiol; 2002 Apr 03; 39(7):1199-203. PubMed ID: 11923046
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.
    Scardi S, Camerini F, Pandullo C, Pollavini G.
    Int J Cardiol; 1991 Aug 03; 32(2):241-8. PubMed ID: 1917174
    [Abstract] [Full Text] [Related]

  • 16. Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients.
    Rezaković DE.
    Am J Cardiol; 1988 Mar 25; 61(9):59E-69E. PubMed ID: 3126637
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
    Akhras F, Hellestrand K, Whalley D, Jackson G.
    Int J Cardiol; 1994 Mar 01; 43(3):251-6. PubMed ID: 8181883
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
    Longobardi G, Ferrara N, Leosco D, Abete P, Furgi G, Cacciatore F, Corbi G, Pescatore R, Rengo F.
    Cardiovasc Drugs Ther; 2004 Sep 01; 18(5):363-70. PubMed ID: 15717138
    [Abstract] [Full Text] [Related]

  • 19. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
    Fox KM, Dargie HJ, Deanfield J, Maseri A.
    Br Heart J; 1991 Aug 01; 66(2):151-5. PubMed ID: 1909152
    [Abstract] [Full Text] [Related]

  • 20. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
    Whalley DW, Hellestrand KJ.
    Aust N Z J Med; 1990 Oct 01; 20(5):677-81. PubMed ID: 2126727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.